Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash to Debt 1.11
SGYP's Cash to Debt is ranked lower than
62% of the 758 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 4.00 vs. SGYP: 1.11 )
Ranked among companies with meaningful Cash to Debt only.
SGYP' s Cash to Debt Range Over the Past 10 Years
Min: 0.13  Med: 10000.00 Max: No Debt
Current: 1.11
F-Score: 3
Z-Score: -7.49
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
ROA (%) -105.99
SGYP's ROA (%) is ranked lower than
97% of the 758 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 3.72 vs. SGYP: -105.99 )
Ranked among companies with meaningful ROA (%) only.
SGYP' s ROA (%) Range Over the Past 10 Years
Min: -6858.53  Med: -160.37 Max: -66.95
Current: -105.99
-6858.53
-66.95
ROC (Joel Greenblatt) (%) -18895.31
SGYP's ROC (Joel Greenblatt) (%) is ranked lower than
98% of the 752 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 14.14 vs. SGYP: -18895.31 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
SGYP' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -423053.33  Med: -15143.46 Max: -549.59
Current: -18895.31
-423053.33
-549.59
EBITDA Growth (3Y)(%) 32.50
SGYP's EBITDA Growth (3Y)(%) is ranked higher than
86% of the 544 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 7.00 vs. SGYP: 32.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
SGYP' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.5  Med: 37.15 Max: 176.4
Current: 32.5
-7.5
176.4
EPS Growth (3Y)(%) 49.50
SGYP's EPS Growth (3Y)(%) is ranked higher than
90% of the 498 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 6.30 vs. SGYP: 49.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
SGYP' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -17.4  Med: 46.10 Max: 166.3
Current: 49.5
-17.4
166.3
» SGYP's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-08-10)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

SGYP Guru Trades in Q2 2015

Louis Moore Bacon 325,000 sh (New)
Paul Tudor Jones 55,415 sh (+381.16%)
John Paulson 5,781,500 sh (+175.89%)
» More
Q3 2015

SGYP Guru Trades in Q3 2015

Steven Cohen 256,208 sh (New)
John Paulson 9,000,000 sh (+55.67%)
Paul Tudor Jones 42,506 sh (-23.30%)
Louis Moore Bacon 225,000 sh (-30.77%)
» More
Q4 2015

SGYP Guru Trades in Q4 2015

Jim Simons 397,600 sh (New)
Louis Moore Bacon 665,000 sh (+195.56%)
Steven Cohen 320,400 sh (+25.05%)
John Paulson 9,000,000 sh (unchged)
Paul Tudor Jones 22,074 sh (-48.07%)
» More
Q1 2016

SGYP Guru Trades in Q1 2016

Paul Tudor Jones 48,161 sh (+118.18%)
John Paulson 11,090,000 sh (+23.22%)
Steven Cohen Sold Out
Louis Moore Bacon Sold Out
Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SGYP

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)